Xiaoming Yang
Showed as senior author that the liver-secreted protein hepassocin protects against age-related liver senescence and helps the liver regenerate
Corresponding author, State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Academy of Military Medical Sciences · School of Pharmacy, Guangdong Pharmaceutical University · School of Basic Medical Sciences, University of South China
Yang is the corresponding author on the 2026 study identifying Hepassocin (HPS) as a hepatokine that keeps aging livers regenerating. His laboratory traced how HPS activates AMPK through an ANXA2-ERK-p90RSK-LKB1 relay, restraining mTOR activity, and showed that this axis weakens with age — leaving HPS-deficient aged mice with elevated mTOR signalling, impaired autophagy, and a much-reduced ability to recover liver mass after injury.
The work points to restoring HPS or AMPK signalling, rather than blocking mTOR directly, as a route to counteracting age-related liver dysfunction and regeneration failure.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK YAN2026B Senior and corresponding author; his laboratory showed that the hepatokine Hepassocin activates AMPK and protects against liver senescence and regeneration failure. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Xiaoming Yang.
ShowHide
- Yang Yang Showed as first author that the liver-secreted protein hepassocin protects against age-related liver senescence and helps the liver regenerate
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.